ARCTURUS THERAPEUTICS HOLDIN (ARCT)

US03969T1097 - Common Stock

25.73  -0.9 (-3.38%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
166.80M206.00M12.40M9.50M20.80M
Operating Expenses
245.00M193.80M215.20M81.10M46.30M
Research and Development
192.13M147.80M173.80M57.80M33.60M
Selling, General, and Administrative Expenses
52.87M46.10M41.50M23.20M12.70M
Operating Income
-78.21M12.20M-202.90M-71.50M-25.50M
Interest Income/Expense
16.36M-1.50M-800.00K-600.00K-500.00K
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
33.95MN/AN/AN/AN/A
Income Before Taxes
-27.89M10.60M-203.70M-72.10M-26.00M
Income Tax
1.83M1.30MN/AN/AN/A
Net Income
-29.73M9.30M-203.70M-72.10M-26.00M
EBITDA
-75.25M13.73M-201.71M-70.62M-24.82M
 
Per Share Data
EPS Diluted Total Ops
-1.120.35-7.74-3.55-2.15
Non GAAP EPS
-1.040.34-7.74-3.39-2.04
 
Statistics
Profit Margin
-17.82%4.51%-1642.74%-758.95%-125.00%
Operating Profit Margin
-46.89%5.92%-1636.29%-752.63%-122.60%

All data in USD

Charts